Citation

91 FR 8261

Canonical document for this Federal Register citation.

Prospective Grant of an Exclusive Patent License: In Vivo Manufactured Anti-CD19 Chimeric Antigen Receptor (CAR) Products for the Treatment or Prevention of B Cell Mediated Autoimmune Diseases Friday, February 20, 2026 91 FR 8261